(EPAM) EPAM Systems - Overview
Sector: TechnologyIndustry: Information Technology Services | Exchange NYSE (USA) | Currency USD | Market Cap: 7.498m | Total Return -25.4% in 12m
Stock: Software Development, Cloud, Data, Customer Experience, Cybersecurity
Total Rating 52
Risk 86
Buy Signal -0.19
| Risk 5d forecast | |
|---|---|
| Volatility | 44.3% |
| Relative Tail Risk | -13.7% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.48 |
| Alpha | -42.74 |
| Character TTM | |
|---|---|
| Beta | 1.116 |
| Beta Downside | 1.631 |
| Drawdowns 3y | |
|---|---|
| Max DD | 59.06% |
| CAGR/Max DD | -0.38 |
EPS (Earnings per Share)
Revenue
Description: EPAM EPAM Systems March 04, 2026
EPAM Systems, Inc. delivers digital platform engineering and software development services globally. The companys offerings include engineering, cloud services, data analytics, AI, customer experience design, and cybersecurity. These services are critical for businesses undergoing digital transformation, a significant trend across all industries.
EPAM also provides operational solutions and full lifecycle software product and platform development, from research to maintenance. This comprehensive service model is typical for IT consulting firms that aim to be end-to-end partners for their clients.
EPAM serves diverse sectors, including financial services, consumer goods, retail, travel, software, hi-tech, business information, media, life sciences, healthcare, and other emerging verticals. Investors can find more detailed financial analysis on ValueRay.
Headlines to watch out for
- Global IT spending directly impacts EPAMs service demand
- Wage inflation for skilled engineers compresses EPAMs margins
- Geopolitical instability in Eastern Europe disrupts EPAMs operations
- Competition from offshore IT services firms pressures pricing
- Client demand for AI and cloud transformation drives revenue growth
Piotroski VR‑10 (Strict, 0-10) 9.5
| Net Income: 377.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.12 > 0.02 and ΔFCF/TA 1.40 > 1.0 |
| NWC/Revenue: 28.53% < 20% (prev 33.95%; Δ -5.42% < -1%) |
| CFO/TA 0.13 > 3% & CFO 654.9m > Net Income 377.7m |
| Net Debt (-1.15b) to EBITDA (658.6m): -1.75 < 3 |
| Current Ratio: 2.59 > 1.5 & < 3 |
| Outstanding Shares: last quarter (55.3m) vs 12m ago -3.65% < -2% |
| Gross Margin: 28.26% > 18% (prev 0.31%; Δ 2.80k% > 0.5%) |
| Asset Turnover: 113.1% > 50% (prev 99.53%; Δ 13.54% > 0%) |
| Interest Coverage Ratio: 67.35 > 6 (EBITDA TTM 658.6m / Interest Expense TTM 7.62m) |
Altman Z'' 6.27
| A: 0.32 (Total Current Assets 2.53b - Total Current Liabilities 976.9m) / Total Assets 4.90b |
| B: 0.46 (Retained Earnings 2.27b / Total Assets 4.90b) |
| C: 0.11 (EBIT TTM 513.2m / Avg Total Assets 4.83b) |
| D: 1.87 (Book Value of Equity 2.29b / Total Liabilities 1.22b) |
| Altman-Z'' Score: 6.27 = AAA |
Beneish M -2.93
| DSRI: 0.96 (Receivables 1.11b/1.00b, Revenue 5.46b/4.73b) |
| GMI: 1.09 (GM 28.26% / 30.68%) |
| AQI: 1.00 (AQ_t 0.42 / AQ_t-1 0.42) |
| SGI: 1.15 (Revenue 5.46b / 4.73b) |
| TATA: -0.06 (NI 377.7m - CFO 654.9m) / TA 4.90b) |
| Beneish M-Score: -2.93 (Cap -4..+1) = A |
What is the price of EPAM shares?
As of March 25, 2026, the stock is trading at USD 133.04 with a total of 630,371 shares traded.
Over the past week, the price has changed by -2.51%, over one month by +3.28%, over three months by -36.37% and over the past year by -25.39%.
Over the past week, the price has changed by -2.51%, over one month by +3.28%, over three months by -36.37% and over the past year by -25.39%.
Is EPAM a buy, sell or hold?
EPAM Systems has received a consensus analysts rating of 3.95.
Therefore, it is recommended to buy EPAM.
- StrongBuy: 7
- Buy: 7
- Hold: 6
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the EPAM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 191.2 | 43.7% |
| Analysts Target Price | 191.2 | 43.7% |
EPAM Fundamental Data Overview March 25, 2026
P/E Trailing = 20.1964
P/E Forward = 10.8578
P/S = 1.3739
P/B = 2.0234
P/EG = 0.8162
Revenue TTM = 5.46b USD
EBIT TTM = 513.2m USD
EBITDA TTM = 658.6m USD
Long Term Debt = 25.0m USD (from longTermDebt, last quarter)
Short Term Debt = 37.2m USD (from shortTermDebt, last quarter)
Debt = 143.7m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -1.15b USD (from netDebt column, last quarter)
Enterprise Value = 6.35b USD (7.50b + Debt 143.7m - CCE 1.30b)
Interest Coverage Ratio = 67.35 (Ebit TTM 513.2m / Interest Expense TTM 7.62m)
EV/FCF = 10.36x (Enterprise Value 6.35b / FCF TTM 612.7m)
FCF Yield = 9.66% (FCF TTM 612.7m / Enterprise Value 6.35b)
FCF Margin = 11.23% (FCF TTM 612.7m / Revenue TTM 5.46b)
Net Margin = 6.92% (Net Income TTM 377.7m / Revenue TTM 5.46b)
Gross Margin = 28.26% ((Revenue TTM 5.46b - Cost of Revenue TTM 3.91b) / Revenue TTM)
Gross Margin QoQ = 30.07% (prev 27.24%)
Tobins Q-Ratio = 1.29 (Enterprise Value 6.35b / Total Assets 4.90b)
Interest Expense / Debt = 1.60% (Interest Expense 2.31m / Debt 143.7m)
Taxrate = 23.97% (34.5m / 143.8m)
NOPAT = 390.2m (EBIT 513.2m * (1 - 23.97%))
Current Ratio = 2.59 (Total Current Assets 2.53b / Total Current Liabilities 976.9m)
Debt / Equity = 0.04 (Debt 143.7m / totalStockholderEquity, last quarter 3.68b)
Debt / EBITDA = -1.75 (Net Debt -1.15b / EBITDA 658.6m)
Debt / FCF = -1.88 (Net Debt -1.15b / FCF TTM 612.7m)
Total Stockholder Equity = 3.68b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.83% (Net Income 377.7m / Total Assets 4.90b)
RoE = 10.27% (Net Income TTM 377.7m / Total Stockholder Equity 3.68b)
RoCE = 13.86% (EBIT 513.2m / Capital Employed (Equity 3.68b + L.T.Debt 25.0m))
RoIC = 10.54% (NOPAT 390.2m / Invested Capital 3.70b)
WACC = 9.75% (E(7.50b)/V(7.64b) * Re(9.91%) + D(143.7m)/V(7.64b) * Rd(1.60%) * (1-Tc(0.24)))
Discount Rate = 9.91% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -3.08%
[DCF] Terminal Value 73.38% ; FCFF base≈578.4m ; Y1≈616.0m ; Y5≈741.1m
[DCF] Fair Price = 200.2 (EV 9.69b - Net Debt -1.15b = Equity 10.84b / Shares 54.1m; r=9.75% [WACC]; 5y FCF grow 7.20% → 3.0% )
EPS Correlation: 38.23 | EPS CAGR: 7.45% | SUE: 0.96 | # QB: 1
Revenue Correlation: 66.38 | Revenue CAGR: 5.01% | SUE: 1.42 | # QB: 6
EPS next Quarter (2026-06-30): EPS=3.13 | Chg7d=+0.008 | Chg30d=+0.064 | Revisions Net=+1 | Analysts=17
EPS current Year (2026-12-31): EPS=12.78 | Chg7d=+0.022 | Chg30d=+0.228 | Revisions Net=+12 | Growth EPS=+11.1% | Growth Revenue=+6.4%
EPS next Year (2027-12-31): EPS=13.94 | Chg7d=+0.027 | Chg30d=-0.092 | Revisions Net=+2 | Growth EPS=+9.1% | Growth Revenue=+7.3%
[Analyst] Revisions Ratio: +0.09 (6 Up / 5 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 5.0% (Discount Rate 9.9% - Earnings Yield 5.0%)
[Growth] Growth Spread = +1.0% (Analyst 6.0% - Implied 5.0%)
P/E Forward = 10.8578
P/S = 1.3739
P/B = 2.0234
P/EG = 0.8162
Revenue TTM = 5.46b USD
EBIT TTM = 513.2m USD
EBITDA TTM = 658.6m USD
Long Term Debt = 25.0m USD (from longTermDebt, last quarter)
Short Term Debt = 37.2m USD (from shortTermDebt, last quarter)
Debt = 143.7m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -1.15b USD (from netDebt column, last quarter)
Enterprise Value = 6.35b USD (7.50b + Debt 143.7m - CCE 1.30b)
Interest Coverage Ratio = 67.35 (Ebit TTM 513.2m / Interest Expense TTM 7.62m)
EV/FCF = 10.36x (Enterprise Value 6.35b / FCF TTM 612.7m)
FCF Yield = 9.66% (FCF TTM 612.7m / Enterprise Value 6.35b)
FCF Margin = 11.23% (FCF TTM 612.7m / Revenue TTM 5.46b)
Net Margin = 6.92% (Net Income TTM 377.7m / Revenue TTM 5.46b)
Gross Margin = 28.26% ((Revenue TTM 5.46b - Cost of Revenue TTM 3.91b) / Revenue TTM)
Gross Margin QoQ = 30.07% (prev 27.24%)
Tobins Q-Ratio = 1.29 (Enterprise Value 6.35b / Total Assets 4.90b)
Interest Expense / Debt = 1.60% (Interest Expense 2.31m / Debt 143.7m)
Taxrate = 23.97% (34.5m / 143.8m)
NOPAT = 390.2m (EBIT 513.2m * (1 - 23.97%))
Current Ratio = 2.59 (Total Current Assets 2.53b / Total Current Liabilities 976.9m)
Debt / Equity = 0.04 (Debt 143.7m / totalStockholderEquity, last quarter 3.68b)
Debt / EBITDA = -1.75 (Net Debt -1.15b / EBITDA 658.6m)
Debt / FCF = -1.88 (Net Debt -1.15b / FCF TTM 612.7m)
Total Stockholder Equity = 3.68b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.83% (Net Income 377.7m / Total Assets 4.90b)
RoE = 10.27% (Net Income TTM 377.7m / Total Stockholder Equity 3.68b)
RoCE = 13.86% (EBIT 513.2m / Capital Employed (Equity 3.68b + L.T.Debt 25.0m))
RoIC = 10.54% (NOPAT 390.2m / Invested Capital 3.70b)
WACC = 9.75% (E(7.50b)/V(7.64b) * Re(9.91%) + D(143.7m)/V(7.64b) * Rd(1.60%) * (1-Tc(0.24)))
Discount Rate = 9.91% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -3.08%
[DCF] Terminal Value 73.38% ; FCFF base≈578.4m ; Y1≈616.0m ; Y5≈741.1m
[DCF] Fair Price = 200.2 (EV 9.69b - Net Debt -1.15b = Equity 10.84b / Shares 54.1m; r=9.75% [WACC]; 5y FCF grow 7.20% → 3.0% )
EPS Correlation: 38.23 | EPS CAGR: 7.45% | SUE: 0.96 | # QB: 1
Revenue Correlation: 66.38 | Revenue CAGR: 5.01% | SUE: 1.42 | # QB: 6
EPS next Quarter (2026-06-30): EPS=3.13 | Chg7d=+0.008 | Chg30d=+0.064 | Revisions Net=+1 | Analysts=17
EPS current Year (2026-12-31): EPS=12.78 | Chg7d=+0.022 | Chg30d=+0.228 | Revisions Net=+12 | Growth EPS=+11.1% | Growth Revenue=+6.4%
EPS next Year (2027-12-31): EPS=13.94 | Chg7d=+0.027 | Chg30d=-0.092 | Revisions Net=+2 | Growth EPS=+9.1% | Growth Revenue=+7.3%
[Analyst] Revisions Ratio: +0.09 (6 Up / 5 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 5.0% (Discount Rate 9.9% - Earnings Yield 5.0%)
[Growth] Growth Spread = +1.0% (Analyst 6.0% - Implied 5.0%)